{
    "clinical_study": {
        "@rank": "126191", 
        "arm_group": [
            {
                "arm_group_label": "severe periodontitis group", 
                "arm_group_type": "Experimental", 
                "description": "non-surgical periodontal therapy"
            }, 
            {
                "arm_group_label": "Moderate periodontitis group", 
                "arm_group_type": "Experimental", 
                "description": "non-surgical periodontal therapy"
            }, 
            {
                "arm_group_label": "healthy control", 
                "arm_group_type": "No Intervention", 
                "description": "No treatment"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the present study is to identify the novel periodontal disease biomarkers\n      using differentially expressed microRNA in the saliva. The severity of chronic periodontal\n      diseases and the time of pre- and post-treatment are major classification criteria. The\n      obtained data will secure the foundation for the development of a new non-invasive\n      diagnostic methods for early diagnosis & prognosis prediction of periodontal disease."
        }, 
        "brief_title": "Diagnosis of Periodontal Disease Using Genetic Marker in Saliva", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Periodontitis", 
        "condition_browse": {
            "mesh_term": [
                "Periodontal Diseases", 
                "Periodontitis", 
                "Chronic Periodontitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        A. Severe Periodontal Disease\n\n          -  Patients with chronic severe periodontitis\n\n          -  Primary treatment of periodontal scaling, subgingival curettage is required, and the\n             general progress of the protocol agreed with the basic periodontal therapy patients.\n\n          -  subjects agreed collecting saliva and gingival crevicular fluid and physicochemical\n             tests and genetic testing\n\n        A. Moderate Periodontal Disease\n\n          -  Patients with chronic moderate periodontitis\n\n          -  Primary treatment of periodontal scaling, subgingival curettage is required, and the\n             general progress of the protocol agreed with the basic periodontal therapy patients.\n\n          -  subjects agreed collecting saliva and gingival crevicular fluid and physicochemical\n             tests and genetic testing\n\n        C. Healthy Control\n\n          -  Healthy periodontal patients ( more than 20 permanent teeth are present , in all\n             parts of deep periodontal pockets measuring 4mm or less, and height is 2mm or less\n             clinical attachment person)\n\n          -  subjects agreed collecting saliva and gingival crevicular fluid and physicochemical\n             tests and genetic testing\n\n        Exclusion Criteria:\n\n          -  Received periodontal treatment within the last six months\n\n          -  recently taken antibiotics within 3 months if you need a prescription antibiotic\n             prophylaxis\n\n          -  taking the drug can affect periodontal status for a long period of time\n\n          -  pregnant or breastfeeding\n\n          -  In case of oral inflammatory mucosal disease (Lichen planus, etc.)\n\n          -  A history of alcoholism or drug abuse if\n\n          -  other special systemic disease (high blood pressure)\n\n          -  ages under 18"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "18", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 19, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02069574", 
            "org_study_id": "2013-0940"
        }, 
        "intervention": {
            "arm_group_label": [
                "severe periodontitis group", 
                "Moderate periodontitis group"
            ], 
            "intervention_name": "non-surgical periodontal therapy", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 20, 2014", 
        "location": {
            "contact": {
                "email": "shkimperio@amc.seoul.kr", 
                "last_name": "Su-Hwan Kim, PhD", 
                "phone": "82-2-3010-5797"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "138-736"
                }, 
                "name": "ASAN Medical Center"
            }, 
            "investigator": {
                "last_name": "Su-Hwan Kim, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "3", 
        "official_title": "Identification of Novel Periodontal Disease Biomarkers Using microRNA Expression in Saliva", 
        "overall_contact": {
            "email": "shkimperio@amc.seoul.kr", 
            "last_name": "Su-Hwan Kim, PhD.", 
            "phone": "82-2-3010-5797"
        }, 
        "overall_official": {
            "affiliation": "Asan Medical Center", 
            "last_name": "Su-Hwan Kim, PhD.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Korea: Ministry of Food and Drug Safety", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Expression level of MicroRNAs using Microarray", 
            "safety_issue": "No", 
            "time_frame": "Change from Baseline in expression level of MicroRNAs at 1,6,12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02069574"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Asan Medical Center", 
            "investigator_full_name": "Su-Hwan Kim", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Pro-inflammatory biomarker : interleukin(IL)-1a, IL-1b, IL-6, IL-8\nMatrix metalloproteinase(MMP) : MMP-8, MMP-9\nAnti-inflammatory biomarker: IL-10, inhibitor of MMP (TIMP)-1", 
            "measure": "Expression level of cytokines using multiple cytokine analysis", 
            "safety_issue": "No", 
            "time_frame": "Change from Baseline in expression level of cytokines at 1,6,12 months"
        }, 
        "source": "Asan Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Asan Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}